GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $394,000 | -1.3% | 9,045 | 0.0% | 0.06% | -3.5% |
| Q4 2021 | $399,000 | +17.4% | 9,045 | +1.5% | 0.06% | +7.5% |
| Q3 2021 | $340,000 | -9.3% | 8,910 | -5.4% | 0.05% | -10.2% |
| Q2 2021 | $375,000 | +5.6% | 9,415 | -5.4% | 0.06% | +1.7% |
| Q1 2021 | $355,000 | -12.6% | 9,955 | -9.9% | 0.06% | -20.5% |
| Q4 2020 | $406,000 | -4.2% | 11,045 | -2.0% | 0.07% | -8.8% |
| Q3 2020 | $424,000 | -11.3% | 11,267 | -3.8% | 0.08% | -17.5% |
| Q2 2020 | $478,000 | -5.2% | 11,707 | -12.0% | 0.10% | -44.3% |
| Q1 2020 | $504,000 | -26.6% | 13,298 | -9.0% | 0.17% | -4.9% |
| Q4 2019 | $687,000 | +11.5% | 14,613 | +1.2% | 0.18% | +2.8% |
| Q3 2019 | $616,000 | +3.5% | 14,443 | -2.8% | 0.18% | +3.5% |
| Q2 2019 | $595,000 | -3.1% | 14,863 | +1.2% | 0.17% | -7.0% |
| Q1 2019 | $614,000 | +1.8% | 14,683 | -7.0% | 0.18% | -11.1% |
| Q4 2018 | $603,000 | -2.7% | 15,793 | +2.3% | 0.21% | +14.9% |
| Q3 2018 | $620,000 | +3.5% | 15,436 | +3.8% | 0.18% | -2.7% |
| Q2 2018 | $599,000 | – | 14,866 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |